pharma news today glp-1 today Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Pipeline Update: August 2025

However, GLP-1 also has a positive effect on gut flora, nurturing a healthy microbiome that aids digestion and supports overall health

By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan

Achieve sustainable weight loss and improve metabolism with medical supervision in Lincoln Park, IL.

Recent Findings Newer generation GLP-1 based therapies have become more effective for the treatment of overweight and obesity, with data supporting tirzepatide as the most effective, followed by semaglutide and then liraglutide

What makes them unique among other T...